Recent Finacing
Recent Raise
Amadix develops non-invasive blood-based molecular diagnostics and AI-driven assays for early cancer screening, including ColoFast for colorectal cancer and tests for lung, pancreatic, and prostate cancers.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
